US FDA Changes Data Source For GDUFA II Facility Fee Setting
Agency primarily uses application data instead of facility self-identification lists to determine FY 2018 generic drug user fees.
Agency primarily uses application data instead of facility self-identification lists to determine FY 2018 generic drug user fees.